Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 190792-72-4 | MDL No. : | MFCD11618002 |
Formula : | C6H14ClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LKKCSUHCVGCGFA-RIHPBJNCSA-N |
M.W : | 151.63 | Pubchem ID : | 12228413 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 39.68 |
TPSA : | 46.25 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.7 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.74 |
Log Po/w (WLOGP) : | 1.05 |
Log Po/w (MLOGP) : | 0.57 |
Log Po/w (SILICOS-IT) : | 0.39 |
Consensus Log Po/w : | 0.55 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.25 |
Solubility : | 8.6 mg/ml ; 0.0567 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.29 |
Solubility : | 7.77 mg/ml ; 0.0512 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.1 |
Solubility : | 122.0 mg/ml ; 0.802 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.97 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.8 g | Stage #1: (1R,2S)-2-aminocyclohexan-1-ol With (-)-dibenzoyl-L-tartaric acid monohydrate In ethanol at 20 - 25℃; for 2.66667h; Reflux; Stage #2: With hydrogenchloride In water monomer | 8 Example 8 In the reaction flask, intermediate 3 (11.5 g, 0.1 mol) was mixed with 45 mL of ethanol, and completely dissolved under stirring. The temperature was controlled at 20-25°C, and L-DBTA-H2O (18.8g, 0.05mol) and 90mL of ethanol mixed solution were added dropwise, and the dropwise addition was completed in 40 minutes, and then the temperature was heated and refluxed for 2 hours; the reaction system was lowered to 0°C by gradient cooling. , a solid was precipitated in the process, and the diastereoisomeric salt was obtained by filtration, which was recrystallized with 90 mL of ethanol, and the white solid salt was obtained by filtration. The white solid salt was added with 3N aqueous hydrochloric acid solution to pH=2-3, extracted with ethyl acetate twice (for L-DBTA recovery), the water layer was distilled under reduced pressure, and toluene was added with water during the finishing process until the solid crude product was obtained , after beating with ethanol and drying, 5.8 g of off-white solid (1R,2S)-2-aminocyclohexanol hydrochloride was obtained. |
[ 68327-04-8 ]
(1S,2S)-2-Aminocyclopentanol hydrochloride
Similarity: 0.92
[ 225791-13-9 ]
(1S,2R)-2-Aminocyclopentanol Hydrochloride
Similarity: 0.92
[ 68327-04-8 ]
(1S,2S)-2-Aminocyclopentanol hydrochloride
Similarity: 0.92
[ 225791-13-9 ]
(1S,2R)-2-Aminocyclopentanol Hydrochloride
Similarity: 0.92
[ 68327-04-8 ]
(1S,2S)-2-Aminocyclopentanol hydrochloride
Similarity: 0.92
[ 225791-13-9 ]
(1S,2R)-2-Aminocyclopentanol Hydrochloride
Similarity: 0.92